FDA D.I.S.C.O. Burst Edition: FDA approval of Tecartus (brexucabtagene autoleucel) for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia
0:00
2:30
Listen to a soundcast of the October 1, 2021 FDA approval of Tecartus (brexucabtagene autoleucel) for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
Otros episodios de "FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)"
No te pierdas ningún episodio de “FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)”. Síguelo en la aplicación gratuita de GetPodcast.